Promega Caspase-Glo™ 8 and Caspase-Glo™ 9 Assay Systems

Caspase-Glo™ Assay is a homogeneous luminescent assay that measures caspase-8 or caspase-9 activity.

Includes: Caspase-Glo 8 Buffer or Caspase-Glo 9 Buffer; Caspase-Glo 8 Substrate or Caspase-Glo 9 Substrate

Catalog Number	Mfr. No.	For Use With (Application)	Kit Contents	Quantity
PRG8201	Promega G8201	Caspase-8 Activation Determination (EC50), Detection of Caspase-8 Activity, Caspase-8 Inhibition Determination (IC50)	1 x 1 Bottle Caspase-Glo™ 8 substrate, 1 x 10mL Caspase-Glo™ 8 Buffer, 1 x 30μL MG-132 inhibitor	10 mL
PRG8200	Promega G8200	Caspase-8 Activation Determination (EC50), Detection of Caspase-8 Activity, Caspase-8 Inhibition Determination (IC50)	1 x 1 Bottle Caspase-Glo™ 8 substrate, 1 x 2.5mL Caspase-Glo™ 8 Buffer, 1 x 7.5μL MG-132 inhibitor	2.5 mL
PRG8210	Promega G8210	Caspase-9 Activation Determination (EC50), Caspase-9 Activity Determination, Caspase-9 Inhibition Determination (IC50)	1 x 1 Bottle Caspase-Glo™ 9 substrate, 1 x 2.5mL Caspase-Glo™ 9 Buffer, 1 x 7.5μL MG-132 inhibitor	2.5 mL
PRG8211	Promega G8211	Caspase-9 Activation Determination (EC50), Caspase-9 Activity Determination, Caspase-9 Inhibition Determination (IC50)	1 x 1 Bottle Caspase-Glo™ 9 substrate, 1 x 10mL Caspase-Glo™ 9 Buffer, 1 x 30μL MG-132 inhibitor	10 mL

Description

• A Luminescent Assay That Measures Caspase-8 or 9 Activity
• Decreased assay time and less enzyme needed
• Homogeneous add-mix-measure protocol amenable to automation

• U.S. Patent 6,602,677, Australian Patent 754312 and other patents pending.
• The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024; 5,674,713; and 5,700,673.

Specifications

• Test Time: 0.5 to 1 hr.
• Content And Storage: -30°C to -10°C